Healthcare DIVE January 18, 2022
Greg Slabodkin

The three test makers said at last week’s J.P. Morgan conference they see opportunities for direct-to-consumer, digitally-connected testing for diseases beyond COVID-19.

The COVID-19 pandemic has enabled consumers to perform rapid self-tests in the comfort of their homes, a convenient option that test makers like Abbott Laboratories, Becton Dickinson and Quidel are hoping to cash in on with over-the-counter and direct-to-consumer testing for other diseases beyond the coronavirus.

The development and adoption of at-home tests that detect coronavirus infection and the integration of digital health technologies are paving the way for broader consumer use of diagnostics for other ailments that don’t have to be performed at a hospital, a physician’s office or a pharmacy.

Abbott CEO Robert Ford said at...

Today's Sponsors

H1
ZeOmega
Holon

Today's Sponsors

SalesSparx
Canton & Company

Today's Sponsor

Premier

 
Topics: Biotechnology, Conferences / Podcast, Healthcare System, Home, Patient / Consumer, Pharma, Pharma / Biotech, Public Health / COVID, Trends
The Future of Nursing Is at Home
Gaps and Racial Disparities Found in Care Transitions
Study: Medicare needs to improve reimbursements for home care to entice more ACO investment
Characteristics of Home-Based Care Provided by Accountable Care Organizations
5 ways COVID-19 has changed healthcare IT